TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

TRANSPLANTATION PROCEEDINGS is a distinguished journal published by Elsevier Science Inc, focused on the field of transplantation and surgery. With a publication history spanning over five decades, from 1969 to 2024, this journal has consistently provided a platform for researchers and practitioners to share significant findings and advancements in organ transplantation and related surgical techniques. The journal is renowned for its rigorous peer-review process and has achieved a respectable impact factor within its categories, ranking in the Q3 quartile for both Surgery and Transplantation as of 2023. With Scopus rankings placing it in the 47th percentile in Medicine (Surgery) and the 43rd percentile in Medicine (Transplantation), TRANSPLANTATION PROCEEDINGS serves as a vital resource for academics and medical professionals seeking to stay updated on the latest empirical research, clinical practices, and innovative methodologies in the field. While it does not operate under an open-access model, the journal ensures that critical insights and data are accessible to its audience, enhancing the global discourse in transplantation science. For those dedicated to advancing transplant medicine, this journal represents an invaluable collection of knowledge and a forum for fostering innovative approaches to improve patient outcomes.

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Pediatric Nephrology, published by Springer, is a leading international journal dedicated to advancing the field of pediatric nephrology and enhancing the health of children with renal disorders. With its ISSN 0931-041X and E-ISSN 1432-198X, this esteemed journal has been in circulation since 1987 and has established itself as a vital resource for researchers and clinicians alike. Featuring a robust impact factor and categorized in Q1 for Pediatrics, Perinatology and Child Health, and Q2 for Nephrology, Pediatric Nephrology stands at the forefront of medical literature, reflecting its commitment to disseminating high-quality research. The journal is particularly noted for its comprehensive scope, encompassing clinical studies, innovative treatments, and cutting-edge research findings that shape pediatric kidney care. Located in Germany and reaching a global audience, this journal not only supports the academic community but also plays a crucial role in improving health outcomes for children worldwide. Access to its valuable content is essential for any practitioner or researcher invested in the evolving landscape of pediatric medicine.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

JOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.

Current Transplantation Reports, published by SpringerNature, is a leading journal in the field of transplantation science, offering vital insights into the cutting-edge developments in transplant medicine and related disciplines. With an impressive array of quartile rankings, including Q2 in Nephrology and Transplantation, and Q3 in Hepatology and Immunology for 2023, this journal plays a significant role in bridging research and clinical practice. Focused on fostering innovation, the journal spans a wide spectrum of topics, from surgical advances to immunological considerations of transplant procedures. It serves as an invaluable resource for researchers, healthcare professionals, and students interested in the latest advancements and data in transplantation, recognizing the importance of disseminating knowledge in this evolving field. Although currently not designated as Open Access, it provides rigorous peer-reviewed articles that contribute to the academic community's understanding of transplantation scenarios and challenges faced in clinical settings.

Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.

The Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.